levamisole has been researched along with Pyoderma Gangrenosum in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Agnihothri, R; Gadarowski, MB; Plovanich, M; Scott, G | 1 |
| Joyce, JC; Keith, PJ; Wilson, BD | 1 |
| Cao, L; Dominguez, AR; Jeong, HS; Layher, H; Vandergriff, T | 1 |
3 other study(ies) available for levamisole and Pyoderma Gangrenosum
| Article | Year |
|---|---|
Pyoderma gangrenosum associated with levamisole-adulterated cocaine in a c-ANCA positive patient.
Topics: Adrenal Cortex Hormones; Antibodies, Antineutrophil Cytoplasmic; Betamethasone; Chronic Disease; Cocaine-Related Disorders; Diagnosis, Differential; Drug Contamination; Female; Humans; Levamisole; Maxillary Sinusitis; Middle Aged; Prednisone; Pyoderma Gangrenosum | 2021 |
Pyoderma gangrenosum: a possible cutaneous complication of levamisole-tainted cocaine abuse.
Topics: Administration, Oral; Biopsy, Needle; Cocaine-Related Disorders; Drug Contamination; Female; Follow-Up Studies; Humans; Immunohistochemistry; Levamisole; Middle Aged; Prednisone; Pyoderma Gangrenosum; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2015 |
Pyoderma gangrenosum (PG) associated with levamisole-adulterated cocaine: Clinical, serologic, and histopathologic findings in a cohort of patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Biopsy, Needle; Cocaine; Cohort Studies; Drug Contamination; Female; Humans; Immunohistochemistry; Levamisole; Male; Middle Aged; Prognosis; Pyoderma Gangrenosum; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2016 |